Arg913Gln of SLC12A3 gene promotes development and progression of end-stage renal disease in Chinese type 2 diabetes mellitus
- 25 July 2017
- journal article
- research article
- Published by Springer Nature in Molecular and Cellular Biochemistry
- Vol. 437 (1-2) , 203-210
Abstract
Whether the Arg913Gln variation (rs11643718, G/A) of SLC12A3 contributes to diabetic nephropathy (DN) remains controversial. We undertook a case–control study to evaluate the association of the SLC12A3-Arg913Gln variation with the risk of end-stage renal disease (ESRD) in Chinese type 2 diabetes mellitus (T2DM) patients undergoing hemodialysis, and analyzed the genotype–phenotype interaction. Unrelated Chinese T2DM patients (n = 372) with diabetic retinopathy were classified into the non-DN (control) group (n = 151; duration of T2DM >15 years, no signs of renal involvement) and the DN–ESRD group (n = 221; ESRD due to T2DM, receiving hemodialysis). Polymerase chain reaction-direct sequencing was used to genotype the SLC12A3-Arg913Gln variation for all participants. The frequency of the GA+AA genotype in the DN–ESRD group was significantly higher than that of the non-DN group (23.1 vs. 9.9%; adjusted OR 2.2 (95% CI 1.3–4.5), P = 0.019). In the non-DN group, GA+AA carriers had a significantly higher urinary albumin excretion rate (UAER) and diastolic blood pressure compared with GG carriers (both P < 0.05). The SLC12A3-Arg913Gln variation may be associated with increased blood pressure and UAER and, therefore, could be used to predict the development and progression of DN–ESRD in Chinese T2DM patients undergoing hemodialysis.Keywords
Funding Information
- Project of National Natural Science Foundation of China (81471012, 81270876, 30771022 and 30971384)
- Shanghai leading talent (SLJ15055)
- Program of Education Research from Shanghai Jiaotong University of Medicine (YB150612)
- National Institute of Diabetes and Digestive and Kidney Diseases Grant (SC1DK104821)
This publication has 33 references indexed in Scilit:
- Nephrology in ChinaNature Reviews Nephrology, 2013
- Pro12Ala Polymorphism in thePPARGGene Contributes to the Development of Diabetic Nephropathy in Chinese Type 2 Diabetic PatientsDiabetes Care, 2009
- The Epidemiology of Hemoglobin Levels in Patients With Type 2 DiabetesAmerican Journal of Kidney Diseases, 2006
- South-Asian Type 2 Diabetic Patients Have Higher Incidence and Faster Progression of Renal Disease Compared With Dutch-European Diabetic PatientsDiabetes Care, 2006
- USRDS 2004 annual data reportAmerican Journal of Kidney Diseases, 2005
- The Thiazide-Sensitive Na+-Cl- Cotransporter Gene, C1784T, and Adrenergic Receptor-β3 Gene, T727C, May Be Gene Polymorphisms Susceptible to the Antihypertensive Effect of Thiazide DiureticsHypertension Research, 2004
- Development and progression of nephropathy in type 2 diabetes: The United Kingdom Prospective Diabetes Study (UKPDS 64)Kidney International, 2003
- Genetic Variants of Thiazide-Sensitive NaCl-Cotransporter in Gitelman’s Syndrome and Primary HypertensionHypertension, 2000
- Molecular Cloning, Expression Pattern, and Chromosomal Localization of the Human Na–Cl Thiazide-Sensitive Cotransporter (SLC12A3)Genomics, 1996
- Gitelman's variant of Barter's syndrome, inherited hypokalaemic alkalosis, is caused by mutations in the thiazide-sensitive Na–Cl cotransporterNature Genetics, 1996